A meta-analysis of case-control studies of the association of migraine and patent foramen ovale

详细信息    查看全文

• 作者：Hisato Takagi ; MD ; PhD ; ^{kfgth973@ybb.ne.jp" class="auth_mail" title="E-mail the corresponding author} ; Takuya Umemoto ; MD ; PhD ; for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group
• 关键词：Meta-analysis ; Migraine ; Patent foramen ovale
• 刊名：Journal of Cardiology
• 出版年：2016
• 出版时间：June 2016
• 年：2016
• 卷：67
• 期：6
• 页码：493-503
• 全文大小：1878 K

文摘

To establish quantitative evidence, we performed the first meta-analysis of case-control studies assessing the relationship between migraine and patent foramen ovale (PFO).

Methods

MEDLINE and EMBASE were searched through April 2015 using PubMed and OVID. Eligible studies were case-control studies reporting PFO (or migraine) prevalence in migraine patients versus no-migraine subjects (or PFO patients versus no-PFO subjects).

Results

Of 395 potentially relevant articles screened initially, 21 eligible studies enrolling a total of 5572 participants were identified and included. Pooled analyses demonstrated statistically significant 3.36-fold migraine-with-aura [odds ratio (OR), 3.36; 95% confidence interval (CI), 2.04–5.55; p < 0.00001] and 2.46-fold migraine-with/without-aura prevalence (OR, 2.46; 95% CI, 1.55–3.91; p = 0.0001) but statistically non-significant 1.30-fold migraine-without-aura prevalence (OR, 1.30; 95% CI, 0.85–1.99; p = 0.22) in PFO patients relative to no-PFO subjects.

Conclusions

PFO is associated with 3.4-fold migraine-with-aura and 2.5-fold migraine-with/without-aura prevalence but unassociated with migraine-without-aura prevalence.